- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Kyowa Hakko Kirin Co Ltd+ Add to Watchlist
4151:JP1,299.0 JPY 15.0 1.17%
As of 01:00:00 ET on 11/26/2014.
Company Profile for Kyowa Hakko Kirin Co Ltd (4151)
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.
Kyowa Hakko Kirin Co Ltd
Key Executives for Kyowa Hakko Kirin Co Ltd (4151)
|Nobuo HanaiPresident||Hiroyuki KawaiExecutive Vice President|
|Kazuyoshi TachibanaManaging Executive Officer||Toshifumi MikayamaManaging Executive Officer|
|Fumihiro NishinoManaging Executive Officer|